Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Late-onset heart failure after treatment for breast cancer.

Ewer SM, Pham DD.

Cancer. 2019 Aug 27. doi: 10.1002/cncr.32483. [Epub ahead of print] No abstract available.

PMID:
31454417
2.

Trastuzumab Cardiotoxicity After Anthracycline Exposure Constitutes a Complex and Clinically Important Entity.

Ewer MS, Ewer SM.

JACC Heart Fail. 2019 Sep;7(9):805-807. doi: 10.1016/j.jchf.2019.04.012. Epub 2019 Aug 7. No abstract available.

PMID:
31401098
3.

Guest Editorial: Is Cardio-oncology Ready for Algorithms?

Ewer SM.

Eur Cardiol. 2018 Aug;13(1):62-63. doi: 10.15420/ecr.2018.13.1.GE2. Review. No abstract available.

4.

Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma.

Catino AB, Hubbard RA, Chirinos JA, Townsend R, Keefe S, Haas NB, Puzanov I, Fang JC, Agarwal N, Hyman D, Smith AM, Gordon M, Plappert T, Englefield V, Narayan V, Ewer S, ElAmm C, Lenihan D, Ky B.

Circ Heart Fail. 2018 Mar;11(3):e004408. doi: 10.1161/CIRCHEARTFAILURE.117.004408.

5.

Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma.

Narayan V, Keefe S, Haas N, Wang L, Puzanov I, Putt M, Catino A, Fang J, Agarwal N, Hyman D, Smith AM, Finkelman BS, Narayan HK, Ewer S, ElAmm C, Lenihan D, Ky B.

Clin Cancer Res. 2017 Jul 15;23(14):3601-3609. doi: 10.1158/1078-0432.CCR-16-2869. Epub 2017 Feb 14.

6.

Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit.

Ewer MS, Ewer SM.

Br J Cancer. 2016 Dec 6;115(12):1441-1442. doi: 10.1038/bjc.2016.381. Epub 2016 Nov 22. No abstract available.

7.

Mechanisms underlying trastuzumab activity are complex.

Ewer MS, Ewer SM.

Nat Rev Cardiol. 2015 Nov;12(11):669. doi: 10.1038/nrcardio.2015.136. Epub 2015 Sep 29. No abstract available.

PMID:
26416005
8.

Cardiotoxicity of anticancer treatments.

Ewer MS, Ewer SM.

Nat Rev Cardiol. 2015 Nov;12(11):620. doi: 10.1038/nrcardio.2015.133. Epub 2015 Aug 20. No abstract available.

PMID:
26292190
9.

The anthracycline-trastuzumab interaction: a lesson in not jumping to confusion.

Ewer MS, Ewer SM.

Trends Pharmacol Sci. 2015 Jun;36(6):321-2. doi: 10.1016/j.tips.2015.04.007. Epub 2015 May 15. No abstract available.

PMID:
25987322
10.

Cardiotoxicity of anticancer treatments.

Ewer MS, Ewer SM.

Nat Rev Cardiol. 2015 Sep;12(9):547-58. doi: 10.1038/nrcardio.2015.65. Epub 2015 May 12. Review. Erratum in: Nat Rev Cardiol. 2015 Nov;12(11):620.

PMID:
25962976
11.

Post-TAVR ventricular septal defect in the presence of subaortic membrane.

Lee CW, Hegde SM, Ewer SM, Lozonschi L.

Echocardiography. 2015 Mar;32(3):604-6. doi: 10.1111/echo.12802. Epub 2014 Oct 17. No abstract available.

PMID:
25323427
12.

Enigmas regarding the true extent and impact of tyrosine kinase inhibitor-related cardiotoxicity.

Ewer MS, Ewer SM.

Expert Opin Drug Saf. 2013 Sep;12(5):611-4. doi: 10.1517/14740338.2013.828033. Epub 2013 Aug 12.

PMID:
23931567
13.

Classification of left ventricular diastolic function using American Society of Echocardiography Guidelines: agreement among echocardiographers.

Chapman CB, Ewer SM, Kelly AF, Jacobson KM, Leal MA, Rahko PS.

Echocardiography. 2013 Oct;30(9):1022-31. doi: 10.1111/echo.12185. Epub 2013 Apr 1.

PMID:
23551740
14.
15.

Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy.

Harbeck N, Ewer MS, De Laurentiis M, Suter TM, Ewer SM.

Ann Oncol. 2011 Jun;22(6):1250-8. doi: 10.1093/annonc/mdq543. Epub 2010 Nov 26. Review.

16.

Returns to physician human capital: evidence from patients randomized to physician teams.

Doyle JJ Jr, Ewer SM, Wagner TH.

J Health Econ. 2010 Dec;29(6):866-82. doi: 10.1016/j.jhealeco.2010.08.004. Epub 2010 Aug 24.

PMID:
20869783
17.

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know.

Ewer MS, Ewer SM.

Nat Rev Cardiol. 2010 Oct;7(10):564-75. doi: 10.1038/nrcardio.2010.121. Review.

PMID:
20842180
18.

Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.

Ewer MS, Ewer SM.

J Clin Oncol. 2010 Sep 1;28(25):3901-4. doi: 10.1200/JCO.2010.30.6274. Epub 2010 Aug 2. No abstract available.

PMID:
20679626
19.

Long-term cardiac safety of dose-dense anthracycline therapy cannot be predicted from early ejection fraction data.

Ewer MS, Ewer SM.

J Clin Oncol. 2009 Dec 20;27(36):6073-5. doi: 10.1200/JCO.2009.25.5091. Epub 2009 Nov 9. No abstract available.

PMID:
19901128
20.

Anthracycline cardiotoxicity: why are we still interested?

Ewer SM, Ewer MS.

Oncology (Williston Park). 2009 Mar;23(3):234-5, 239. No abstract available.

21.

Cardiotoxicity profile of trastuzumab.

Ewer SM, Ewer MS.

Drug Saf. 2008;31(6):459-67. Review.

PMID:
18484781
22.

Images in Cardiovascular Medicine. Left-sided ablation via a patent foramen ovale.

Ewer SN, Kocheril AG.

Circulation. 1998 Jan 27;97(3):290. No abstract available.

PMID:
9462532
23.
24.

Fatal pulmonary edema following intravenous "freebase" cocaine use.

Allred RJ, Ewer S.

Ann Emerg Med. 1981 Aug;10(8):441-2.

PMID:
7258760

Supplemental Content

Support Center